New Delhi: Health Minister Mansukh Mandaviya on Thursday met with representatives of pharmaceutical companies and reviewed the status and adequacy of covid-19 drugs and production capacity to effectively handle any situation domestic situation in the context of a sudden increase in the number of cases in some countries.
Mandaviya, who met representatives of the companies online, said, “India’s pharmaceutical industry is strong, resilient and responsive. Thanks to their strength, we can not only meet the reduced demand during the pandemic, but also supply medicine to 150 countries. This was achieved without sacrificing quality and without increasing drug prices.”
Pharmaceutical companies are required to closely monitor the global supply chain scenario. They are also required to closely monitor the production and availability of APIs and formulations of essential drugs for COVID management. They are required to ensure adequate stock and availability of all drugs including COVID drugs in the supply chain up to the retail level.
Pharmaceutical companies welcomed the timely review meeting chaired by the Minister and pledged their continued support. They expressed confidence that they would be able to manage the covid drug supply chain.
Meanwhile, the Ministry of Health said that passengers arriving in India from China, Hong Kong, Japan, South Korea, Singapore and Thailand will have to undergo mandatory RT-PCR testing before departure and download reports. to the Air Suvidha portal from 1 January 2023.
catch them all Business newsletter, Market News, Hot news Events and Latest news Update on Live Mint. Download Mint . News Application to get Daily Market Updates.
